Ventyx Biosciences Inc (NASDAQ: VTYX) is 89.47% higher on its value in year-to-date trading and has touched a low of $1.87 and a high of $40.58 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The VTYX stock was last observed hovering at around $3.74 in the last trading session, with the day’s gains setting it 0.94%.
Currently trading at $4.68, the stock is 4.33% and -23.11% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.27 million and changing 25.13% at the moment leaves the stock -66.86% off its SMA200. VTYX registered -88.05% loss for a year compared to 6-month loss of -67.45%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -10.69% gain in the last 1 month and extending the period to 3 months gives it a 121.80%, and is 10.38% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.99% over the week and 7.88% over the month.
Ventyx Biosciences Inc (VTYX) has around 80 employees, a market worth around $329.94M and $0.00M in sales. Distance from 52-week low is 150.94% and -88.47% from its 52-week high. The company has generated returns on investments over the last 12 months (-75.54%).
The EPS is expected to grow by 19.10% this year
The shares outstanding are 59.24M, and float is at 56.85M with Short Float at 14.73%.
Ventyx Biosciences Inc (VTYX) Insider Activity
The most recent transaction is an insider sale by Mohan Raju, the company’s CEO AND PRESIDENT. SEC filings show that Mohan Raju sold 4,312 shares of the company’s common stock on Apr 02 ’24 at a price of $5.40 per share for a total of $23299.0. Following the sale, the insider now owns 1.58 million shares.
Ventyx Biosciences Inc disclosed in a document filed with the SEC on Apr 02 ’24 that Krueger Christopher W (CHIEF BUSINESS OFFICER) sold a total of 1,651 shares of the company’s common stock. The trade occurred on Apr 02 ’24 and was made at $5.40 per share for $8921.0. Following the transaction, the insider now directly holds 0.28 million shares of the VTYX stock.
Still, SEC filings show that on Apr 02 ’24, Nuss John (CHIEF SCIENTIFIC OFFICER) disposed off 1,651 shares at an average price of $5.40 for $8921.0. The insider now directly holds 264,998 shares of Ventyx Biosciences Inc (VTYX).
